Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies

Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 1:19–25

Benvenuto D, Angeletti S, Giovanetti M, Bianchi M, Pascarella S, Cauda R, Ciccozzi M, Cassone A (2020) Evolutionary analysis of SARS-CoV-2: how mutation of non-structural protein 6 (NSP6) could affect viral autophagy. J Infect 81(1):e24–e27

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X (2020) A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med

Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92(4):418–423

Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trial Research Group (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. The Lancet. 359(9323):2072-7

Clark LK, Green TJ, Petit CM (2021) Structure of nonstructural protein 1 from SARS-CoV-2. J Virol 95(4)

Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):1–3

de Lima Menezes G, da Silva RA (2020) Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1). J Biomol Struct Dyn:1–1.

de Lima Menezes G, da Silva RA (2020) Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1). J Biomol Struct Dyn. 1–1.

Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo MÁ, Urquiza J, Ramírez D, Alonso C, Campillo NE, Martinez A (2020) COVID-19: drug targets and potential treatments. J Med Chem 63(21):12359–12386

Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O’Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 583(7816):459–68.

Hosseini M, Chen W, Xiao D, Wang C (2020) Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs. Precision Clin Med

Huang C, Lokugamage KG, Rozovics JM, Narayanan K, Semler BL, Makino S (2011) SARS coronavirus NSP1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to NSP1-induced RNA cleavage. PLoS Pathog 7(12):e1002433

Irwin JJ, Shoichet BK (2005) ZINC—a free database of commercially available compounds for virtual screening. J Chem Information Modeling. 45(1):177–182

Jia Z, Yan L, Ren Z, Wu L, Wang J, Guo J, Zheng L, Ming Z, Zhang L, Lou Z, Rao Z (2019) Delicate structural coordination of the severe acute respiratory syndrome coronavirus Nsp13 upon ATP hydrolysis. Nucleic Acids Res 47(12):6538–6550

Laskowski RA, MacArthur MW, Thornton JM (2006) PROCHECK: validation of protein-structure coordinates.

Lemke A, Kiderlen AF, Kayser O (2005) Amphotericin b. Appl Microbiol Biotechnol 68(2):151–162

Meshari A, Motwalli O (2020) In silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins. J Biomol Struct Dyn 1–11

Mirza MU, Froeyen M (2020) Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase. J Pharmaceutical Anal 10(4):320–328

Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, Tseng CTK, Makino S, Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, Tseng CT, Makino S (2008) Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol 82(9):4471–4479

Reva BA, Finkelstein AV, Skolnick J (1998) What is the probability of a chance prediction of a protein structure with an rmsd of 6 å? Folding Design 3(2):141–147

Rohl CA, Strauss CE, Misura KM, Baker D (2004) Protein structure prediction using Rosetta. Methods Enzymol 383:66–93

Sakai Y, Kawachi K, Terada Y, Omori H, Matsuura Y, Kamitani W (2017) Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication. Virology 510:165–174

Schwede T, Kopp J, Guex N (2003) Peitsch MC (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31(13):3381–3385

Sharma A, Tiwari V, Sowdhamini R (2020) Computational search for potential COVID-19 drugs from FDA-approved drugs and small molecules of natural origin identifies several anti-virals and plant products. J Biosci 45(1):1–8

Shu T, Huang M, Wu D, Ren Y, Zhang X, Han Y, Mu J, Wang R, Qiu Y, Zhang DY, Zhou X (2020) SARS-Coronavirus-2 Nsp13 possesses NTPase and RNA helicase activities that can be inhibited by bismuth salts. Virologica Sinica. 35:321–329

van Duin D, Bonomo RA (2016) Ceftazidime/avibactam and ceftolozane/tazobactam: second-generation β-lactam/β-lactamase inhibitor combinations. Clin Infect Dis 63(2):234–241

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269–271

World Health Organization, 2020

Xu X, Lou Z, Ma Y, Chen X, Yang Z, Tong X, Zhao Q, Xu Y, Deng H, Bartlam M, Rao Z (2009) Crystal structure of the C-terminal cytoplasmic domain of non-structural protein 4 from mouse hepatitis virus A59. PLoS ONE 4(7):e6217

Yuen CK, Lam JY, Wong WM, Mak LF, Wang X, Chu H, Cai JP, Jin DY, To KK, Chan JF, Yuen KY (2020) SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerging Microbes Infect 9(1):1418–1428